American Journal of Alzheimer’s Disease & Other Dementias

Impact Factor: 2.7

Editor-In-Chief: Raymond Chuen-Chung Chang

Discipline: Aging, Gerontology

Description:

American Journal of Alzheimer’s Disease and Other Dementias® (AJADD) accepts original papers from professionals and researchers on the frontlines of Alzheimer’s care, dementia, and clinical depression, including those who deal with Alzheimer’s patients every day. AJADD is a peer-reviewed, open access journal. In every issue, you will find down-to-earth clinical information on:  The latest research on Alzheimer’s disease from the molecular underpinnings of the disease to its associated behaviors.Practical medical, psychiatric, and nursing issues such as assessment and management of problem behaviors, communication difficulties, dealing with delusions and other psychotic features, apathy, effects of physical activity, integrated treatment approaches, new and changing pharmacotherapies, orientation behaviors, and hospice use. AJADD also includes information on management of concurrent medical issues in the patient with dementia.New and forthcoming diagnostic tools such as computerized testing for mild cognitive impairment and other aspects of cognitive testing, as well as high technology resources for sophisticated disease characterization. AJADD also provides information on the clinical features and management of non-Alzheimer’s dementias. Psychosocial issues such as dealing with staff caregivers’ distress, improving caregivers’ communication skills, helping patients and families to deal with a diagnosis of Alzheimer’s disease or another dementia, and patients’ perceptions and preferences.Practice-oriented clinical research from the frontiers of neurology and genetics, including sleep-wake states, targeting glutamate excitotoxicity, cholesterol and apolipoprotein E, and other aspects of the underlying biology that causes the symptoms of dementia. AJADD also reports on the latest clinical trials that focus on medications for the symptoms of dementia and the disease process.Administrative and legal issues such as coding, consumer evaluation of adult day-care services, cost-effectiveness of special care units, dangerous wandering, end-stage dementia, informed consent, Medicare coverage for cognitively impaired residents, supervision of high-risk fall dementia patients, and vulnerable populations and avoidable hospitalizations.By 2025, it is estimated that there will be about 34 million people in the world with some form of Alzheimer’s disease or other dementia. To stay ahead of the latest research, clinical practices and procedures, and administrative issues, subscribe to American Journal of Alzheimer’s Disease and Other Dementias® today!This journal is a member of the Committee on Publication Ethics (COPE).If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC), currently 3000 USD is payable*. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons licence.*The APC is subject to taxes where applicable. Please see further details here.This journal changed its publication mode from subscription to open access in January 2020. Content from 1999-2019 is hosted free-access. Please see this page for information on reuse rights of archival material. Submit your manuscript today at https://mc.manuscriptcentral.com/AJAD.